Urotensin I CAS NO.83930-33-0
Urotensin I CAS NO.83930-33-0
TECHNICAL SPECIFICATIONS
| Item | Specification |
|---|---|
| Product Name | Urotensin I |
| CAS NO. | 83930-33-0 |
| Appearance | White to off-white lyophilized powder |
| Molecular Formula | C210H340N62O67S2 |
| Molecular Weight | 4869.55g/mol |
| Purity (RP-HPLC) | ≥ 95.0% |
| Solubility | Soluble in water, phosphate-buffered saline (PBS), or dilute acetic acid (e.g., 0.1% v/v). It is recommended to first dissolve in a small volume of 0.1% acetic acid or sterile water to prepare a 0.1–1.0 mg/mL stock solution. |
| Endotoxin | < 1.0 EU/mg |
| Biological Activity | Urotensin I is a potent vasoactive and osmoregulatory peptide, primarily acting as an agonist for the urotensin receptor (UT, GPR14) but with distinct functional profiles compared to Urotensin II. It is involved in cardiovascular regulation, stress response, and osmoregulation. Bioactivity can be validated by vasoconstriction assays in isolated vessels or calcium mobilization assays in UT-expressing cells. |
| Storage Conditions | Lyophilized powder: Store desiccated at –20 °C or below, protected from light, for long-term stability. Reconstituted solution: Aliquot and store at ≤ –20 °C; avoid repeated freeze-thaw cycles. For extended stability, store at –80 °C. |
| Stock Location | Stock in USA |
| MOQ | 1g |
1.MECHANISM OF ACTION
Urotensin I exerts its biological effects by binding to the urotensin receptor UT (GPR14), primarily coupling to Gq/11 to activate phospholipase C and increase intracellular calcium mobilization. This signaling cascade modulates vascular smooth muscle contraction, cardiac function, and osmoregulatory pathways, with additional effects on corticotropin-releasing factor (CRF) systems and stress response. The peptide's disulfide bridge and extended structure contribute to receptor recognition and stability, allowing it to influence diverse physiological processes including blood pressure regulation, fluid homeostasis, and neuroendocrine stress axis activation.
2.PRODUCT INDICATIONS
This peptide is indicated for research applications focused on cardiovascular physiology, osmoregulation, and stress response mechanisms. It is utilized in in vitroassays with UT-expressing cells to study calcium signaling, vasoconstriction, and receptor activation. In in vivostudies, it is administered to investigate blood pressure regulation, fluid balance, and neuroendocrine stress responses in preclinical models. The product also serves as a reference standard for receptor binding studies, immunohistochemistry, and functional assays to explore the role of the urotensin system in hypertension, heart failure, and stress-related disorders.
3.CLINICAL EFFICACY OF PRODUCT
Urotensin I has no clinical efficacy or safety profile, as it is strictly a research reagent for preclinical investigations. The peptide has not undergone clinical trials, regulatory evaluation, or safety assessment for diagnostic or therapeutic use in humans. While preclinical studies demonstrate its involvement in cardiovascular regulation and stress responses, these findings remain exploratory and have not been translated into validated clinical interventions. Any potential therapeutic applications would require the development of stable analogs or modulators with comprehensive pharmacokinetic and safety evaluations.
4.DELIVERY & SHIPPING
We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight
We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.
